RE:RE:RE:New Press Release - Kane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve(TM) Antimicrobial Wound GelThe marketing strategy is not clear, but no one should be selling their stock under $1, so we don't need to know the plan until all of the deals are done.
Perhaps they are just doing deals with companies that have the best foothold in certain countries, so took RMT for their good toehold in UAE. Marketing companies can load their site with bs, so perhaps RMT just has a few salespeople in the rest of MENA. Marc said the big guys (in Europe I thought he meant) were very interested in the bag system, so I thought a deal could be made with a major for Europe and ROW too, but today a tiny 10M population deal gets made.
I've seen lots of companies with a multinational channel partner fire them a few years later for non-perfomance. The more partners you have marketing, the more possibility of them giving you more headaches and administration, but if he's picking the best in each country then that makes no headaches and the admin is worth it.